Data de publicação: 09/04/2020 - 16:00
A Fiocruz research has observed that the drug Atazanavir, used against HIV, was able to inhibit viral replication and to reduce the production of proteins that are related to the inflammatory process in the lungs, and therefore to the worsening of the clinical symptoms of the disease. Specialists have also looked into the combined use of atazanavir and ritonavir, another drug used to fight HIV.
The study was published this Monday (April 6) on...
Notícias
Data de publicação: 06/04/2020 - 12:19
Fiocruz is now part of a group of more than 70 scientists and institutions of more than 30 countries in an international coalition to face the Covid-19 epidemic in countries with medium and low income. Launched last Thursday (02/04), the initiative, called Covid-19 Clinical Resarch Coalition, aims to speed up research on the new coronavirus in the areas where the virus may cause serious problems in health systems that are already fragile,...
Notícias
Data de publicação: 31/03/2020 - 14:34
The Foundation started the construction, in Rio de Janeiro, of the Hospital Center for the Covid-19 Pandemic - National Institute of Infectious Diseases, which will assist the state and municipal governments in fighting the disease. The rapid assembly hospital unit will have 200 beds exclusive for intensive and semi-intensive treatment of critical patients infected with the novel coronavirus (Sars-CoV-2). Check out a 3D view here.
Built in...
Notícias
Data de publicação: 31/03/2020 - 13:18
On March 24, the Oswaldo Cruz Foundation launched an express approval process at the Brazilian Registry of Clinical Essays (ReBEC) for clinical research on the Covid-19. The so-called fast track may reduce the normal approval period, which normally takes up to a couple of weeks, to less than 48 hours. Scientists all over the world will be able to have quick access to the modeling of ongoing studies, thus avoiding re-working and...
Notícias
Data de publicação: 31/03/2020 - 12:52
In an interview to the Fiocruz News Agency (AFN), Nísia Trindade Lima comments on the context of the Covid-19 pandemics and the challenges of its arrival in Brazil. The Fiocruz president also lists some of the actions taken by the institution as a response to this public health crisis, from the production of tests to health care to those infected. All departments and units of the Foundation are mobilized to face the epidemics....
Notícias
Data de publicação: 30/03/2020 - 14:04
An unprecedented study, conducted by the research group on Health in the Prisions [Saúde nas Prisões] of the National School of Public Health (Ensp/Fiocruz), and coordinated by Alexandra Sánchez, through technical cooperation with the Public Prosecutor's Office/RJ, analyzed the causes of deaths in the Prison System of the State of Rio de Janeiro (2016-2017). The results indicate that infectious diseases were...
Notícias
Data de publicação: 30/03/2020 - 11:09
Articles on the new coronavirus (Sars-CoV-2) can be published in just 24 hours in the journal Memórias do Instituto Oswaldo Cruz, one of the oldest and most respected scientific journals in Latin America.
Considering the importance of rapid data sharing during the pandemic, the journal provided an express way for the dissemination of research. Already used for work on Zika, chikungunya, yellow fever and Ebola, the Fast Track system...
Notícias
Data de publicação: 20/03/2020 - 13:24
The emergence of SARS-Cov-2 virus in Wuhan, China, in December 2019 led to a local epidemic that rapidly spread to multiple countries in the world, placing remarkable challenges in surveillance and control. On March 16th, 2020, WHO declared1 that the infection associated with SARS-Cov-2, named COVID-19, had spread to more than 100 countries, with more than 160,000 confirmed cases and more than 6,000 deaths globally.
Great uncertainty...
Notícias
Data de publicação: 19/03/2020 - 14:18
The Oswaldo Cruz Foundation (Fiocruz) will be sending a team of professionals to Portuguese-speaking countries in Africa to help organise the response to the new coronavirus pandemic. This cooperation answers to a request by the regional office of the World Health Organization (WHO) in Africa, received by Fiocruz last Sunday (March 15).
According to Fiocruz director of the Fiocruz Global Health Center, Paulo Buss, Brazilian and Portuguese...
Notícias
Data de publicação: 03/03/2020 - 11:33
Given the emergence of agents with the capacity to cause diseases in humans, such as the new coronavirus, the Covid-19, scientists from all over the world have begun to work hard on the search for answers on the behavior of the pathogen. The process is similar to assembling a jigsaw puzzle: at every new research, an increasingly robust set of data takes form, contributing to clarify important characteristics that are crucial to create an...
Notícias
Data de publicação: 20/02/2020 - 14:09
Professors and researchers may apply for the scholarships under the Institutional Internationalization Program - PrInt Fiocruz-Capes. There are open selections for PhDs with Experience Abroad and for Visiting professor.
The PhD with Experience Abroad aims to attract researchers with experience in a foreign country to work at Fiocruz, whose training and professional experience represent an innovative contribution to the Fiocruz Graduate...
Notícias
Data de publicação: 06/02/2020 - 10:25
It is not easy to surprise a scientist as experienced as Carlos Medicis Morel, general coordinator of the Center for Technological Development in Health (CDTS) of the Oswaldo Cruz Foundation (Fiocruz), former president of the institution and former director of TDR, Special Program for Research and Training in Tropical Diseases of the World Health Organization (WHO). But this is exactly what happened in February 2017, when the researcher visited...
Notícias
Data de publicação: 04/02/2020 - 11:40
Starting this week, Brazil will gain a weight boost in the national response to a possible introduction of the novel coronavirus (Covid-2019) in the country. Together with the Pan American Health Organization (PAHO/WHO), specialists from the Laboratory of Respiratory And Measles Virus of the Oswaldo Cruz Institute (IOC/Fiocruz), which acts as the National Reference Center in Respiratory Viruses for the Ministry of Health, promoted the training...
Notícias
Data de publicação: 09/12/2019 - 15:41
Queen Mary University of London, Fiocruz, and Fundação Getúlio Vargas (FGV) have pledged £40,000 each in seed funding for the development of research collaborations following workshops which aimed to establish scalable projects to generate impact in Brazil. The funding will be used to create the “Brazil Accelerator Fund”, applications are opened to the staff of the institutions till january 31st.. At...
Notícias
Data de publicação: 09/12/2019 - 15:30
The experience of Fiocruz when it comes to health and knowledge production, and how this expertise can benefit developing countries, was subject of an exclusive panel at the Nairobi Summit, an event organized jointly by the governments of Kenya and Danmark and by the United Nations Population Fund (Unfpa) that took place on 11/12. The Summit brought together governments, society, scholars and activitists from all over the world to evaluate the...
Notícias
Data de publicação: 18/11/2019 - 14:00
Oswaldo Cruz Foundation (Fiocruz), the University of the Republic of Uruguay (UdelaR) and Pasteur Institute of Montevideo signed a memorandum of understanding for future partnerships between the institutions. The meeting was held at UdelaR’s headquarters in Montevideo, on October 28.
The meeting was attended by the director of the Oswaldo Cruz Institute (IOC/Fiocruz), José Paulo Gagliardi Leite; Fiocruz’s Vice-Presidents...
Notícias
Data de publicação: 07/11/2019 - 14:07
The 2030 Agenda for Sustainable Development is an action plan that will guide the work of the United Nations and its Member States towards sustainable development by 2030. Approved at an international summit held on 25-27 September 2015, the Agenda was agreed by the 193 UN Member States and includes a Declaration, 17 Sustainable Development Goals (SDGs) and 169 goals. The document also has a section on means of implementation and a mechanism for...
Páginas Institucionais (antigas)
Data de publicação: 30/10/2019 - 15:34
Fiocruz and one of the main French research institutions, the National Center of Scientific Research (CNRS, in the French acronym), have made official the continuity of a historical partnership, with a celebratory three-day symposium and the signing of a Memorandum of Understanding (MdU). From 16 to 18 October, the joint event A cooperative agenda for health promoted exchanges between social and human science researchers applied to the health...
Notícias
Data de publicação: 25/10/2019 - 16:48
Representatives of Fiocruz, the United Nations Population Fund (UNFPA) and ministries and institutes of Health of African countries gathered at the Foundation, between October 9th and 11th, to define the priorities of themes and strategies for the next five years of the partnership. The institutions signed a Memorandum of Understanding (MoU) in July and this was the second planning workshop to implement the actions.
“I would like to...
Notícias
Data de publicação: 25/10/2019 - 15:57
The Novartis Group and the Oswaldo Cruz Foundation (Fiocruz) signed, in Rio de Janeiro, a Memorandum of Understanding to formalize the cooperation intention of the two institutions in teaching, research and technological development projects to combat neglected diseases such as Leprosy, Chagas disease, malaria and sickle cell disease. The partnership contemplates the elaboration and joint implementation of initiatives in health research and the...
Notícias
Data de publicação: 14/10/2019 - 15:18
The Oswaldo Cruz Foundation (Fiocruz) and the National Center for Scientific Research of France (CNRS) promote, from 16 to 18 October, the Symposium "A Health Cooperation Agenda". The event, open to the public, marks the signing of the memorandum of technical, scientific and technological cooperation between the two institutions. The Symposium, to be held at the International Salon of the National School of Public Health (Ensp /...
Notícias
Data de publicação: 19/08/2019 - 15:22
Manuel Heitor, the Portuguese Minister for Science and Technology, was at Fiocruz on August 9 to debate a proposal of technical cooperation with the institution, in particular regarding the Atlantic International Research Centre (AIR Centre), a global project for the integration and development of knowledge on climate change and the Atlantic Ocean. The minister was in Rio de Janeiro for the launching of the local office of the initiative,...
Notícias
Data de publicação: 16/08/2019 - 13:35
The vice-mayor of the Chinese city of Shenzhen, Wu Yihuan, visited Oswaldo Cruz Foundation (Fiocruz) on 24 June, when her delegation met with Fiocruz representatives. The meeting was attended by the vice-president of Production and Innovation In Health (VPPIS), Marco Krieger, who was representing the presidency; the coordinator of the Center for Technological Health Development (CDTS), Carlos Morel; the vice-president of Research and Biological...
Notícias
Data de publicação: 16/08/2019 - 11:21
Science and technology are subjects that arouse great interest among young Brazilians, even more than sports and as much as religion. Most of them, however, including those in college, are unable to provide the name of a national research institute or of any Brazilian scientist. This was the result found by the survey called What do young Brazilians think of science and technology? by the National Institute of Science and Technology in Science...
Notícias
Data de publicação: 25/07/2019 - 16:06
The team from the STD and AIDS Clinical Research Laboratory (LapClin-Aids) of the Evandro Chagas National Institute of Infectious Diseases (INI/Fiocruz) received on June 5 the 2018 Community Engagement Award in recognition of the international excellence of its activities for promoting health and citizenship among groups vulnerable to HIV infection. “Community participation in research is fundamental because it is for society that we do...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
